Skip to main content
Toggle navigation
Home
Back
Facebook
Tweet
Print
Corporate Event
Corporate Lunch Symposium: Key Considerations When Choosing a First-Line Treatment Option for Unresectable Hepatocellular Carcinoma (Presented by AstraZeneca)
Saturday, March 23, 2024
12:10 PM – 1:00 PM
MT